
Terumo BCT receives CE mark for Spectra Optia TPE
LAKEWOOD -- Terumo BCT , a global leader in blood component, therapeutic apheresis and cellular technologies, today announced that the SpectraOptia Apheresis System with therapeutic... Read More
Thursday April 6, 2017 0 comments

Terumo BCT receives FDA approval to evaluate cell collection protocol
LAKEWOOD - Terumo BCT , a leader in blood component, therapeutic apheresis and cellular technologies, has received approval from the U.S. Food and Drug Administration to conduct a controlled... Read More
Monday January 7, 2013 0 comments